[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Maplight Therapeutics Inc (MPLT)

Maplight Therapeutics Inc (MPLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 500,762
  • Shares Outstanding, K 42,618
  • Annual Sales, $ 0 K
  • Annual Income, $ -161,150 K
  • EBIT $ -120 M
  • EBITDA $ -121 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.23

Options Overview Details

View History
  • Implied Volatility 121.67% (-21.90%)
  • Historical Volatility 388.26%
  • IV Percentile 22%
  • IV Rank 10.79%
  • IV High 382.63% on 07/23/26
  • IV Low 90.12% on 08/06/26
  • Expected Move (DTE 4) 0.04 (0.36%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 103
  • Volume Avg (30-Day) 470
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 7,326
  • Open Int (30-Day) 7,128
  • Expected Range 11.71 to 11.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-1.27
  • Number of Estimates 6
  • High Estimate $-1.06
  • Low Estimate $-1.42
  • Prior Year $-37.18
  • Growth Rate Est. (year over year) +96.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.10 +29.12%
on 07/28/26
38.92 -69.81%
on 07/20/26
-26.16 (-69.01%)
since 07/14/26
3-Month
9.10 +29.12%
on 07/28/26
40.43 -70.94%
on 07/10/26
-17.54 (-59.88%)
since 05/14/26

Most Recent Stories

More News
MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Reported positive results from the potentially registrational Phase 2 ZEPHYR trial of ML-007C-MA in schizophrenia, supporting advancement into a Phase 3 ZEPHYR-2 trial Continued advancement of ML-007C-MA...

MPLT : 11.75 (+1.47%)
MapLight Therapeutics Announces $150 Million Private Placement Financing 

SAN FRANCISCO and BOSTON, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering...

MPLT : 11.75 (+1.47%)
MapLight Therapeutics' Phase Two Schizophrenia Results Now Shadow Everything Else in the Report

Barchart Research What to Expect from MPLT Earnings MPLT Generated August 12, 2026 Current Price $11.38 EPS Estimate $$-1.40 Consensus Rating Strong Buy Average Move 6.30% MapLight Therapeutics' Phase...

MPLT : 11.75 (+1.47%)
MPLT Investors Have Opportunity to Join MapLight Therapeutics, Inc. Fraud Investigation with SBS Law

LOS ANGELES , Aug. 3, 2026 /PRNewswire/ -- Schall, Brown & Schwartz  LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors...

MPLT : 11.75 (+1.47%)
Stocks Settle Mixed as AI Angst Offsets Easing Geopolitical Tensions

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.02%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.32%. September E-mini...

ALK : 45.96 (-3.24%)
SNDK : 1,641.11 (+7.39%)
SLB : 53.77 (+3.28%)
TRI : 103.61 (-2.32%)
FDXF : 150.29 (-1.12%)
OXY : 58.36 (+1.14%)
FANG : 202.47 (+1.48%)
STX : 973.44 (+5.65%)
WDC : 508.80 (+4.41%)
AMD : 514.39 (+6.50%)
SPY : 776.34 (-0.20%)
FBRX : 76.83 (-0.04%)
MPLT Investors Have Opportunity to Join MapLight Therapeutics, Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of MapLight Therapeutics, Inc. (“MapLight”...

MPLT : 11.75 (+1.47%)
Stocks Fall from Early Highs as Chipmakers Retreat

The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.46%. September E-mini S&P futures...

ALK : 45.96 (-3.24%)
SNDK : 1,641.11 (+7.39%)
OXY : 58.36 (+1.14%)
FANG : 202.47 (+1.48%)
STX : 973.44 (+5.65%)
WDC : 508.80 (+4.41%)
AMD : 514.39 (+6.50%)
SPY : 776.34 (-0.20%)
FBRX : 76.83 (-0.04%)
ADSK : 251.66 (-2.44%)
MU : 971.66 (+2.30%)
BKR : 64.82 (+2.18%)
Stocks Rally as Middle East Tensions Ease

The S&P 500 Index ($SPX ) (SPY ) today is up +0.65%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.56%. September E-mini S&P futures...

ALK : 45.96 (-3.24%)
UAL : 125.34 (-0.80%)
INTU : 345.66 (-3.53%)
CVX : 200.00 (+1.16%)
MBLY : 8.92 (+0.22%)
DDOG : 255.46 (+1.28%)
RKLB : 80.25 (+0.19%)
IONQ : 46.26 (+2.85%)
$IUXX : 30,046.14 (-0.13%)
MPLT : 11.75 (+1.47%)
ZNU26 : 108-225 (+0.12%)
MSFT : 495.40 (-0.30%)
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia

The trial, designed and sized to support registration, met its primary endpoint, with the 210/3 mg BID dose demonstrating a statistically significant improvement in PANSS total score compared to placebo...

MPLT : 11.75 (+1.47%)
MapLight Therapeutics Announces Changes to Board of Directors

SAN FRANCISCO and BOSTON, June 24, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering...

MPLT : 11.75 (+1.47%)

Business Summary

MapLight Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on improving the lives of patients suffering from debilitating central nervous system disorders. The company's lead product candidate includes ML-007C-MA. MapLight Therapeutics Inc. is based in SAN FRANCISCO.

See More

Key Turning Points

3rd Resistance Point 13.28
2nd Resistance Point 12.76
1st Resistance Point 12.26
Last Price 11.75
1st Support Level 11.24
2nd Support Level 10.72
3rd Support Level 10.22

See More

52-Week High 40.43
Fibonacci 61.8% 28.46
Fibonacci 50% 24.76
Fibonacci 38.2% 21.07
Last Price 11.75
52-Week Low 9.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.